Further medicines added to the list of medicines that cannot be parallel exported from the UK

Further medicines added to the list of medicines that cannot be parallel exported from the UK

October 17, 2019

Further to our news story Temporary parallel export ban issued to ensure continued supply of medicines the Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced that a further four medicines are to be added to the list of medicines which must not be parallel exported from the UK. The restriction on the following four lines will be in place from 00:00am 18 October 2019:

  • Alprostadil
  • Beclometasone dipropionate (QVAR)
  • Norethisterone
  • Ranitidine

Read the DHSC/MHRA letter to holders of a wholesale dealer licence

View the latest list of medicines that cannot be parallel exported from the UK (updated 17/10/19)

The list, will continue to be reviewed on an ongoing basis, to include any product that meets the following criteria:

  1. the medicine is required to meet the needs of UK patients;
  2. the medicine is either being parallel exported or is at threat of being parallel exported; and
  3. the export of that medicine is either contributing to, or may contribute to, a shortage of that medicine in the UK.

The list currently includes products such as Adrenaline auto-injectors, Estradiol, Hepatitis B (rDNA) suspension for injection, Levonorgestrel and Progesterone.



Posted in: , ,


More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...